Letter by Tampakis et al Regarding Article, “Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease”
2019 ◽
Vol 33
(7)
◽
pp. 468-472
◽
2019 ◽
Vol 6
◽
pp. 205435811985411
2008 ◽
Vol 19
(1)
◽
pp. 4-7
◽
2014 ◽
Vol 2
(1)
◽
pp. e000011
◽